Owkin is a healthcare AI company that develops privacy-preserving machine learning models and a federated learning platform to enable collaborative biomedical research across hospitals, biopharma, and research institutions. The company applies multi-modal data analysis (e.g., genomics, pathology, imaging, and clinical data) to accelerate biomarker discovery, improve clinical trial design, and support drug discovery and precision medicine efforts.
Estimated Valuation
Powered by
Leadership & Board
- Current Number of Employees
- 396
- Current LinkedIn Followers
- 70,451
Latest Estimated Valuation
- Total Amount Raised
- $50M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $50M
- Latest Funding Round
- Series B
Company Momentum Positive
OWKIN LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
OWKIN had 396 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
OWKIN had 70,451 followers as of October 26, 2026. The number of followers increased by 148 (0.21%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jul 08, 2022 | Series B | $50.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Bristol-Myers Squibb | Series B |
Similar Companies
A snapshot of private companies similar to OWKIN, helping you discover and navigate related company profiles.
